» Articles » PMID: 37491453

Effects of Dietary-based Weight Loss Interventions on Biomarkers of Endothelial Function: a Systematic Review and Meta-analysis

Overview
Journal Eur J Clin Nutr
Date 2023 Jul 25
PMID 37491453
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial dysfunction is closely linked to the development of atherosclerosis. This systematic review and meta-analysis reviewed the evidence on the effect of weight loss, achieved by dietary-based interventions, on biomarkers of endothelial function (EF). Two databases (Medline, Embase) were searched from inception until November 2022 for studies that met the following criteria: 1) adult subjects (≥ 18 years) without exclusion for health status, 2) dietary interventions for weight loss, and 3) measurements of changes in EF biomarkers. Random-effect meta-analysis and meta-regression were performed. Thirty-seven articles including 1449 participants were included in the systematic review. Study duration ranged from 3-52 weeks. Overall, weight loss significantly improved biomarkers of EF [standardised mean difference (SMD):0.65; 95%CI:0.49,0.81; P < 0.001;I = 91.9%]. Subgroup analyses showed weight loss significantly improved levels of E-selectin (P < 0.001), intercellular adhesion molecule-1 (ICAM-1) (P < 0.001), vascular cell adhesion molecule-1 (VCAM-1) (P < 0.001), nitrite/nitrate (NOx) (P < 0.001) and vascular endothelial growth factor (VEGF) (P < 0.001). Conversely, there was no significant improvement for von Willebrand Factor (vWF). Meta-regression analysis revealed that changes in EF biomarkers were not affected by age, BMI, quality of the studies or the amount of weight lost. A significant heterogeneity was observed for the effects of weight loss on changes in EF biomarkers. Dietary-induced weight loss may be associated with biomarkers changes indicating an improvement of EF, and it may represent a potential strategy to reduce atherosclerotic risk.

Citing Articles

Effects of Weight Loss on Endothelium and Vascular Homeostasis: Impact on Cardiovascular Risk.

Tiezzi M, Vieceli Dalla Sega F, Gentileschi P, Campanelli M, Benavoli D, Tremoli E Biomedicines. 2025; 13(2).

PMID: 40002792 PMC: 11853214. DOI: 10.3390/biomedicines13020381.


Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Liu Y, Li J, Lyu J, Howard L, Sibley A, Starr M Cancer Epidemiol Biomarkers Prev. 2024; 34(1):93-99.

PMID: 39400560 PMC: 11717622. DOI: 10.1158/1055-9965.EPI-24-0644.


The Impact of Weight Loss on Inflammation, Oxidative Stress, and Mitochondrial Function in Subjects with Obesity.

Bosch-Sierra N, Grau-Del Valle C, Hermenejildo J, Hermo-Argibay A, Salazar J, Garrido M Antioxidants (Basel). 2024; 13(7).

PMID: 39061938 PMC: 11273387. DOI: 10.3390/antiox13070870.


A novel Mediterranean diet-inspired supplement ameliorates cognitive, microbial, and metabolic deficits in a mouse model of low-grade inflammation.

Pontifex M, Connell E, Le Gall G, Lang L, Pourtau L, Gaudout D Gut Microbes. 2024; 16(1):2363011.

PMID: 38835220 PMC: 11155709. DOI: 10.1080/19490976.2024.2363011.

References
1.
Galley H, Webster N . Physiology of the endothelium. Br J Anaesth. 2004; 93(1):105-13. DOI: 10.1093/bja/aeh163. View

2.
Goncharov N, Nadeev A, Jenkins R, Avdonin P . Markers and Biomarkers of Endothelium: When Something Is Rotten in the State. Oxid Med Cell Longev. 2018; 2017:9759735. PMC: 5733214. DOI: 10.1155/2017/9759735. View

3.
Gimbrone Jr M, Garcia-Cardena G . Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016; 118(4):620-36. PMC: 4762052. DOI: 10.1161/CIRCRESAHA.115.306301. View

4.
Yuyun M, Ng L, Ng G . Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?. Microvasc Res. 2018; 119:7-12. DOI: 10.1016/j.mvr.2018.03.012. View

5.
Varona J, Ortiz-Regalon R, Sanchez-Vera I, Lopez-Melgar B, Garcia-Durango C, Castellano Vazquez J . Soluble ICAM 1 and VCAM 1 Blood Levels Alert on Subclinical Atherosclerosis in Non Smokers with Asymptomatic Metabolic Syndrome. Arch Med Res. 2019; 50(2):20-28. DOI: 10.1016/j.arcmed.2019.05.003. View